South Korean Samsung Group’s biopharmaceutical business is being reorganized into two separate tracks: contract development ...

Samsung Electronics executive chairman Lee Jae-Yong has leveraged global mergers and acquisitions (M&A) to transform Samsung ...

Samsung Epis Holdings aims to boost Bioepis's capabilities and make it the world's top biosimilar company through aggressive R&D and M&A strategies. A key challenge will be the financial capacity ...

Samsung Electronics is drawing renewed attention over the possibility of further mergers and acquisitions in its core ...

Samsung Electronics will acquire Germany’s FläktGroup for 1.5 billion euros ($1.68 billion), marking Samsung’s largest ...

Samsung shares were up 0.3 per cent after it announced the results, leaving the stock down 12 per cent this year, with investors concerned about the company’s strategy and on anxieties that the ...